Citius Oncology (CTOR) Non-Current Assets (2022 - 2026)
Citius Oncology (CTOR) posted Non-Current Assets of $69.39 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 5.5% from $73.4 million a year earlier and down 2.7% from the prior quarter.
Powered by 
Analysis
Citius Oncology (CTOR) Non-Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Citius Oncology's Non-Current Assets came in at $73.4 million, unchanged from FY2024.
- Annual Non-Current Assets shows a three-year compound annual growth rate of 2.7% (FY2022 to FY2025).
- In prior fiscal years, Citius Oncology's Non-Current Assets was $73.4 million in FY2024, $72.57 million in FY2023 (+7.0%) and $67.81 million in FY2022.
- The fiscal Q3 2026 figure stands as the lowest quarterly Non-Current Assets since fiscal Q2 2024.
- On a year-over-year basis, Non-Current Assets has declined in each of the last three quarters, with an average decline of 2.3% over the last four quarters.
- According to Business Quant data, Non-Current Assets for the three prior fiscal quarters was $71.28 million (Q2 2026), $72.83 million (Q1 2026) and $73.4 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Citius Oncology | 108.93 Mn | 108.93 Mn | 1.00 Mn | 69.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.39 Mn |
| Mar 31, 2026 | 71.28 Mn |
| Dec 31, 2025 | 72.83 Mn |
| Sep 30, 2025 | 73.40 Mn |
| Jun 30, 2025 | 73.40 Mn |
| Mar 31, 2025 | 73.40 Mn |
| Dec 31, 2024 | 73.40 Mn |
| Sep 30, 2024 | 73.40 Mn |
| Jun 30, 2024 | 49.15 Mn |
| Mar 31, 2024 | 48.58 Mn |
| Dec 31, 2023 | 72.57 Mn |
| Sep 30, 2023 | 40.00 Mn |
| Jun 30, 2023 | 69.39 Mn |
| Mar 31, 2023 | 68.57 Mn |
| Dec 31, 2022 | 67.81 Mn |
API Access
Citius Oncology Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=CTOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "CTOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=CTOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();